The Peptide CommonsEst. May 2024
Search
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
JH

j.hartmann

TL2 · Oulu

Contributes reviews on supplier material. Based in Oulu.

Joined 4 February 2025 · last posted 4d

79Posts here
4Topics
0Solutions
1.5kLikes received
958Likes given
24Badges
221Days visited
5.2kPosts read

Recent activity

Full stream
  • What a certificate commits its issuer to Replied, post #91 · Analytics › COA interpretation · 24 Jul 2026 · 19 likes Building on post #88 rather than restating it. The distinction between release testing and characterisation is one industrial documents make and retail ones usually do…
  • Osteoarthritis and mechanical versus metabolic improvement Replied, post #6 · Clinical › Comorbidities · 17 Jul 2026 · 0 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
  • When your prescriber and the evidence disagree Replied, post #18 · Clinical › Prescriber conversations · 16 Jul 2026 · 0 likes Agreed on prescriber, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
  • Insurance and replacement policies, compared Replied, post #77 · Sourcing › Logistics · 10 Jul 2026 · 0 likes Everything in post #73 holds. The case it does not cover is the one I have. Split shipments reduce single-point risk and increase the number of transits. Which trade is…
  • Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #8 · Analytics › COA interpretation · 9 Jul 2026 · 30 likes Worth separating two things that post #5 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
  • Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #33 · Pharmacology › Pharmacokinetics · 24 Jun 2026 · 23 likes I think the Peak-to-trough ratio question is answerable and has not been answered, which is a more optimistic position than most of this thread.
  • Gastro-oesophageal reflux: improving or worsening? Replied, post #57 · Clinical › Comorbidities · 19 Jun 2026 · 21 likes Before the thread moves on from gastro-oesophageal reflux — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
  • Secretagogues and glucose tolerance: the mechanistic concern Replied, post #39 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 0 likes Where I part company with post #38, and it is a narrow parting. Whatever the answer on secretagogues and glucose tolerance turns out to be, the method for getting there…
  • Revisiting: The best-written scientific paper you have read Replied, post #36 · Lounge › Off topic · 17 Jun 2026 · 13 likes Two things can be true about best-written scientific paper at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
  • Aggregate verification data across the directory, with caveats Started this topic · Sourcing › Independent verification · 15 Jun 2026 · 47 likes On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. I have spent a fortnight trying to…
  • Angle of injection and whether 90 degrees is always right — the long version Replied, post #24 · Practice › Administration · 15 Jun 2026 · 18 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
  • Prescription portability between countries Replied, post #61 · Access › International · 11 Jun 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…